Armata Pharmaceuticals, Inc. (ARMP) Financials

ARMP Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 112.8 million 125.1 million
2023-06-30 101.2 million 82.1 million
2023-03-31 108.8 million 86.3 million
2022-12-31 95.8 million 59.8 million

ARMP Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -13.2 million -373000
2023-06-30 -12.3 million 261000
2023-03-31 -19.6 million 857000
2022-12-31 -10.0 million 817000

ARMP Net Income

No data available :(

ARMP Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 24.0 million - 41.6 million
2023-06-30 12.5 million - 42.0 million
2023-03-31 25.1 million - 44.9 million
2022-12-31 14.9 million - 48.8 million

ARMP Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 36.1 million
2023-06-30 56.5 million
2023-03-31 36.0 million
2022-12-31 36.0 million

ARMP Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 3.5 million 8.0 million 3.6 million -
2023-06-30 222000 8.3 million 2.4 million -
2023-03-31 2.0 million 9.6 million 2.5 million -
2022-12-31 455000 9.6 million 1.8 million -

ARMP Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 1.2 million 221000
2023-06-30 980000 200000
2023-03-31 796000 230000
2022-12-31 1.1 million 245000

ARMP

Price: $2.82

52 week price:
1.07
5.26

Earnings Per Share: -1.88 USD

P/E Ratio: -2.02

Exchange: ASE

Sector: Healthcare

Industry: Biotechnology

Volume: 6136

Market Capitalization: 119.6 million

Links: